Tested Applications
| Positive WB detected in | mouse testis tissue |
| Positive IHC detected in | mouse testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10272-2-AP targets p19 INK4d in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0415 Product name: Recombinant human P19 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-166 aa of BC001822 Sequence: MLLEEVRAGDRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAESDLHRRDARGLTPLELALQRGAQDLVDILQGHMVAPL Predict reactive species |
| Full Name | cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
| Calculated Molecular Weight | 19 kDa |
| Observed Molecular Weight | 18-20 kDa |
| GenBank Accession Number | BC001822 |
| Gene Symbol | p19 INK4d/CDKN2D |
| Gene ID (NCBI) | 1032 |
| RRID | AB_2078742 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P55273 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for p19 INK4d antibody 10272-2-AP | Download protocol |
| WB protocol for p19 INK4d antibody 10272-2-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The p19 INK4d Polyclonal antibody (Cat# 10272-2-AP) has 19 citations across journals including Blood, Advanced Science, NPJ Aging, Cell Death & Disease, Cell Death Discovery, FASEB Journal, Lab Investigation, Journal of Virology, Frontiers in Immunology, and Kidney360. Research fields span cellular senescence, aging, cancer (hepatocellular carcinoma, medulloblastoma, cervical cancer, T-ALL), kidney fibrosis, diabetic nephropathy, myocardial injury, radiation biology, interferon signaling, and atrial fibrillation. Applications are predominantly WB and IHC in mouse and human samples.
| Species | Application | Title |
|---|---|---|
Blood Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia. | ||
Adv Sci (Weinh) Epigenetic Targeting of Senescent Cells Prevents the Deleterious Effects of Obstructive Sleep Apnea on Growing Skeleton. | ||
NPJ Aging Spontaneous p53 activation in middle-aged C57BL/6 mice mitigates the lifespan-extending adaptive response induced by low-dose ionizing radiation | ||
Cell Death Dis Epimedium protects against dyszoospermia in mice with Pex3 knockout by exerting antioxidant effects and regulating the expression level of P16. | ||
Cell Death Discov The dual HDAC/PI3K inhibitor CUDC-907 inhibits the growth and proliferation of MYC-driven Group 3 medulloblastoma | ||
Cell Prolif Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1/Cip1and p19INK4dupregulation in hepatocellular carcinoma. |





